One Year Into the Pandemic: Evolving COVID-19 Outcomes in Lung Transplant Recipients, a Single-center Experience
Background. In the early months of the coronavirus disease 2019 (COVID-19) pandemic, our center reported a mortality rate of 34% in a cohort of 32 lung transplant recipients with COVID-19 between March and May 2020. Since then, there has been evolving knowledge in prevention and treatments of COVID-...
Main Authors: | Kemarut Laothamatas, MD, Jamie Hum, DNP, Luke Benvenuto, MD, Lori Shah, MD, Harpreet Singh Grewal, MD, Marcus Pereira, MD, MPH, Jenna Scheffert, PharmD, BCPS, Maggie Carroll, PA-C, Margaret Nolan, DNP, Genevieve Reilly, DNP, Philippe Lemaitre, MD, PhD, Bryan P. Stanifer, MD, MPH, Joshua R. Sonett, MD, Frank D’Ovidio, MD, PhD, Hilary Robbins, MD, Selim M. Arcasoy, MD, MPH |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2022-03-01
|
Series: | Transplantation Direct |
Online Access: | http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001296 |
Similar Items
-
Lung Transplantation for Pulmonary AL Amyloidosis
by: Matthew I. Ehrlich, MD, et al.
Published: (2024-03-01) -
Major Publications in the Critical Care Pharmacotherapy Literature: 2021
by: Patrick M. Wieruszewski, PharmD, et al.
Published: (2022-12-01) -
A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19
by: Mark Klein MD, et al.
Published: (2021-11-01) -
Preoperative Venous Thromboembolism Risk as a Predictor of Free Flap Complications in Breast Reconstruction
by: Emily Andersen, MD, et al.
Published: (2023-10-01) -
Well-Being of Israeli Nurse Practitioners During Times of Crisis: A Cross-Sectional Study
by: Beth G. Zalcman MA, MPH, et al.
Published: (2023-11-01)